covid
Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Inducción del parto tras la aplicación de gel de prostaglandina E2: análisis ...
Journal Information
Vol. 45. Issue 6.
Pages 245-254 (January 2002)
Share
Share
Download PDF
More article options
Vol. 45. Issue 6.
Pages 245-254 (January 2002)
Full text access
Inducción del parto tras la aplicación de gel de prostaglandina E2: análisis de los resultados en 1.067 gestantes
Induction of labor after the application of prostaglandin E2 gel: analysis of the results in 1.067 pregnant women
Visits
10421
M.I. Ribau Díez
Corresponding author
miribau@terra.es

Correspondencia: Gran Vía de les Corts Catalanes, 988, 7, 1.°. 08018 Barcelona
, J. Berzosa González
Servicio de Obstetricia y Ginecología. Hospital General Yagüe. Burgos.
This item has received
Article information
Resumen
Objetivo

Estudio retrospectivo de la aplicación de gel de prostaglandina E2 intracervical en embarazadas, evaluando los resultados del parto en gestantes previamente clasificadas, estudiando y comparando las distintas indicaciones de la inducción del parto

Sujetos y métodos

Se analiza las características del parto después de la aplicación de gel de prostaglandina E2 sobre una población de 1.067 gestantes, en el Hospital General Yagüe de Burgos, durante el período comprendido entre enero de 1992 y diciembre de 1997

Resultados

El mayor número de geles se indicó en primíparas, el 65,9%. El embarazo cronológicamente prolongado supuso la mayor indicación de inducción en nuestro hospital, 519 partos del total de partos, seguido de la rotura prematura de membranas

El mayor número de partos se agrupó entre las 41 y 42 semanas de gestación, ya que supuso el 33,8% de todos los partos. Una dosis de gel representó el 86,8% y la aplicación de tres dosis supuso el 2,5%. El intervalo en la aplicación de cada dosis de gel era de 24 h

Conclusión

El gel de prostaglandina E2 es un método alternativo y seguro cuando se induce el parto y conlleva pocas complicaciones. Disminuye el período de dilatación, la dosis de oxitocina y el índice de cesáreas

Palabras clave:
Gel
Prostaglandina
Inducción
Parto
Abstract
Objective

Retrospective study of the endocervical prostaglandin gel application during the pregnancy and evaluation of the results of the deliveries on gestant women classified according to the different induction indications of the deliveries

Subjects and methods

We analyze the delivery characteristics after the E2 prostaglandin gel application on a population of 1067 gestant women at the General Yagüe hospital of Burgos during the period time going from January 1992 to December 1997

Results

The greatest rate of gel indication occurred on primiparas with a 65.9% rate. The chronologically prolonged pregnancy was the induction indication with the greatest number of deliveries with 519 deliveries followed by the premature membrane break

The greatest number of deliveries occurred between the 41 and 42 weeks of gestation with a 33.8%. One dose of gel totaled 86.8% of the inductions and the application of three doses the 2.5%. 24 hours was the period of time between gel dose applications

Conclusions

The prostaglandine gel is a safe alternative method for the delivery induction and with little complications. This method also shortens the dilatation period and the cesareans rate

keywords:
Gel
Prostaglandin
Induction
Delivery
Full text is only aviable in PDF
Bibliografía
[1.]
K.F.Jr. Trofatter.
Endocervical prostaglandin E2 gel for preinduction cervical ripening. Clinical trial results.
J Reprod Med, 38 (1993), pp. 78-82
[2.]
K.A. Hales, W.F. Rayburn, G.L. Turnbull, H.D. Christensen, E. Patatanian.
Double blind comparison of intracervical and intravaginal prostaglandin E2 for cervical ripening and induction of labor.
Am J Obstet Gynecol, 171 (1994), pp. 1087-1091
[3.]
D. Minaretzis, C. Tsionou, I. Papageorgiou, S. Michalas, D. Aravantinos.
Intracervical prostaglandin E2 gel for cervical ripening and labor induction: what is the appropiate dose?.
Gynecol Obstet Invest, 35 (1993), pp. 34-37
[4.]
N. Malik, L. Gittens, D. González, A. Bardeguez, V. Ganesh, J. Apuzzio.
Clinical amnionitis and endometritis in patients with premature rupture of membranes: endocervical prostaglandin E2 gel versus oxytocin for induction of labor.
Obstet Gynecol, 88 (1996), pp. 540-543
[5.]
J.M. O'Brien, B.M. Mercer, N.T. Cleary, B.M. Sibai.
Efficacy of outpatient induction with low-dose intravaginal prostaglandin E2: a randomized, double-blind, placebo-controlled trial.
Am J Obstet Gynecol, 173 (1995), pp. 1855-1859
[6.]
P. Panel, V. Bascou, J.B. De Meeus, G. Magnin.
Maturation cervicale par applications itératives de gel de prostaglandines E2. A propos de 186 cas.
J Gynecol Obstet Biol Reprod Paris, 26 (1997), pp. 386-394
[7.]
P. Gaucherand, M. Delignette, M. Gelas, R.C. Rudigoz.
Déclenchement du travail de l'áccouchement par les prostaglandines.
Rev Fr Gynécol Obstét, 86 (1991), pp. 647-652
[8.]
H. Almström, L. Granström.
Preinductive cervical ripening with Pg E2 gel in term pregnant women with ultrasonically diagnosed intrauterine growth retarded fetuses.
Acta Obstet Gynecol Scand, 70 (1991), pp. 555-559
[9.]
J.K. Chyu, H.T. Strassner.
Prostaglandin E2 for cervical ripening: A randomized comparison of Cervidil versus Prepidil.
Am J Obstet Gynecol, 177 (1997), pp. 606-611
[10.]
M.J.N. Keirse, D. Phil.
Prostaglandins in preinduction cervical ripening: Meta-analysis of worldwide clinical experience.
J Reprod Med, 38 (1993), pp. 89-100
[11.]
ACOG Commitee Opinion: Committe on Obstetrics: Maternal an Fetal Medicine Number 123.
Prostaglandin E2 gel for cervical ripening.
Int J Gynaecol Obstet, 42 (1993), pp. 212-214
[12.]
P. Rix, P. Ladehoff, A.M. Moller, K.A. Tilma, M. Zdravkovic.
Cervical ripening and induction of delivery by local administration of prostaglandin E2 gel or vaginal tablets is equally effective.
Acta Obstet Gynecol Scand, 75 (1996), pp. 45-47
[13.]
J.M. Milliez, D. Jannet, C. Touboul, M. Medjadji, B.J. Paniel.
Maturation of the uterine cervix by repeated intracervical instillation of prostaglandin E2.
Am J Obstet Gynecol, 165 (1991), pp. 523-528
[14.]
E.F. Magann, J.r. Perry KG, J.R. Dockery, J.D. Bass, S.P. Chauhan, J.C. Morrison.
Cervical ripening before medical induction of labor: A comparison of prostaglandin E2, estradiol, and oxytocin.
Am J Obstet Gynecol, 172 (1995), pp. 1702-1708
[15.]
E.P. Bernstein.
Therapeutic considerations for preinduction cervical ripening with intracervical prostaglandin E2 gel.
J Reprod Med, 38 (1993), pp. 73-77
[16.]
F.Y. Nishioka.
Prostaglandin E2 preparations for preinduction cervical ripening. Pharmacy considerations.
J Reprod Med, 38 (1993), pp. 83-88
[17.]
The National Institute of Child Health an Human Development Network of Maternal Fetal Medicine Units.
A clinical trial of induction of labor versus expectant management in postterm pregnancy.
Am J Obstet Gynecol, 170 (1994), pp. 716-723
[18.]
H.S. Warke, R.M. Saraogi, S.M. Sanjwalla.
Prostaglandin E2 gel in ripening of cervix in induction of labour.
J Postgrad Med, 45 (1999), pp. 105-109
[19.]
M. Norman, G. Ekman, A. Malmström.
Prostaglandin E2 induced ripening of the human cervix changes in proteoglycan metabolism.
Obstet Gynecol, 82 (1993), pp. 1013-1020
Copyright © 2002. Sociedad Española de Ginecología y Obstetricia
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos